LINC00996, RPARP‐AS1, SND1‐IT1, and TMPO‐AS1 have emerged as key molecules in the intricate network of tumour pathophysiology, potentially influencing NSCLC progression and patient outcomes. Here, SND1 is linked to neoplasm.